Archives of Neurology · 1982 · 109 citations · 22 references
Life SciencesNeurologyNeuroscienceDementiaNeurochemistryNeuropharmacologyAlzheimer DiseaseAmino Acid NeurochemistryDementia BiomarkersGabaergic NeurochemistryGabaergic SignalingNeurodegenerative DiseasesGabaergic Neurotransmission In Disease
Fifteen patients, 48 to 72 years old, with Alzheimer's disease were studied. Clinical status was assessed by neurologic and neuropsychologic examinations and psychometric testing. Patients were divided into two groups on the basis of clinical assessment: group 1, little mental deterioration, and group 2, serious mental deterioration. Nineteen subjects, 27 to 72 years old, without neurologic disease served as controls. Levels of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), and gamma-aminobutyric acid (GABA) were determined in lumbar CSF by fluorimetric or radioreceptor binding (GABA) methods. The HVA concentrations increased with age in the controls, whereas the GABA levels decreased with age and 5-HIAA levels were not modified. When compared with the age-matched controls, the patients with Alzheimer's disease showed low concentrations of HVA but not of 5-HIAA or GABA. The decrease in HVA level was more pronounced in patients with severe mental deterioration and therefore appeared to be disease related.
22
Cerebral Blood Flow in Dementia
Vladimir Hachinski, L. D. Iliff, E. Zilhka et al. · Archives of Neurology · 1975 · 3.2K citations
Medicine, Neurology, Neuroscience +14
A Standardized Memory Scale for Clinical Use
David Wechsler · The Journal of Psychology · 1945 · 3K citations
The Measurement of Adult Intelligence
Anne Anastasi, David Wechsler · The American Journal of Psychology · 1942 · 732 citations
Aging and Extrapyramidal Function
Patrick L. McGeer, Edith G. McGeer, Junko Suzuki · Archives of Neurology · 1977 · 650 citations